For the top 12 grossing drugs in the U.S., each had an average of 71 patents granted, which almost doubled the time these drugs are protected from generic competition. Many of the granted patents are for minor tweaks. Reform bills are coming, but some critics worry that they won’t necessarily curb abuse.
↧